Trial Profile
A retrospective, observational study to evaluate efficacy and safety of tolvaptan in the treatment of hyponatremia caused by the Syndrome of Inappropriate Antidiuretic Hormone Secretion(SIADH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Therapeutic Use
- 20 Nov 2015 New trial record